Real World Experience With Lorcaserin for Weight Management
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2019
Price : $35 *
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 29 Oct 2019 Status changed from active, no longer recruiting to completed.
- 11 Jun 2019 Results (n= 118) assessing real-world use of lorcaserin for weight management, including in patients diagnosed with T2DM, prediabetes, and metabolic syndrome, presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 22 May 2019 Results presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research